Buscar
Mostrando ítems 51-60 de 816
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data
(2021)
Background: Breast cancer (BC) is the leading cause of cancer death for Chilean women. About 11% of cases are triple-negative (TN) BC. These are characterised by poor prognosis, higher risk of early recurrence and visceral ...
Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study
(2023)
Background Latin American (LA) studies on triple-negative breast cancer (TNBC) and their characteristics are scarce. This forces physicians to make clinical decisions based on data obtained from studies that include ...
Toward RDF Normalization
(Springer Verlag, 2015)
Billions of RDF triples are currently available on the Web through the Linked Open Data cloud (e.g., DBpedia, LinkedGeoData and New York Times). Governments, universities as well as companies (e.g., BBC, CNN) are also ...
Capacidad predictiva de mal pronóstico de la mamografía y ecografía en carcinoma mamario triple negativo
(Universidad de Guayaquil. Facultad de Ciencias Médicas. Escuela de Graduados, 2022)
Antecedentes: Establecer el pronóstico pretratamiento en carcinoma de mama triple negativo (CMTN) permite dirigir el manejo terapéutico. La resonancia magnética cumple este propósito. Sin embargo, los costos asociados a ...
Maca Root (Lepidium meyenii) Extract Increases the Expression of MMP-1 and Stimulates Migration of Triple-Negative Breast Cancer Cells
(2021-01-01)
Maca root (Lepidium meyenii) extract is a worldwide consumed food supplement for sexual dysfunctions, increasing sperm production and its motility, and alleviating menopausal symptoms. Once maca root has a role in cell ...
Analysis of the contribution of immunologically-detectable HER2, steroid receptors and of the "triple-negative" tumor status to disease-free and overall survival of women with epithelial ovarian cancer
(Elsevier Gmbh, Urban & Fischer VerlagJenaAlemanha, 2014)